Cardiac transplantation: current indications, short-and long-term results, economic implications, and future developments.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Cardiac Failure

• Publication date

  1996-06-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/S1071-9164(96)80033-9PMID 8798116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental Induction of Atheroarteriosclerosis by the Synergy of Allergic Injury to Arteries and Lipid-Rich Diet Effect of Repeatedly Injected Foreign Protein in Rabbits Fed a Lipid-Rich, Cholesterol-Poor Diet

  2007cited by this paper
• Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.

  1996cited by this paper
• Clinical status of patients removed from a transplant waiting list rivals that of transplant recipients at significant cost savings.

  1996cited by this paper
• Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.

  1995cited by this paper
• Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy.

  1995cited by this paper
• Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients.

  1995cited by this paper
• Risk factors for late recurrent rejection after heart transplantation: A multiinstitutional, multivariable analysis

  1995cited by this paper
• Improvement in exercise capacity of candidates awaiting heart transplantation.

  1995cited by this paper
• Recovery of nonbeating donor hearts.

  1995cited by this paper
• HeartMate implantable left ventricular assist device: bridge to transplantation and future applications.

  1995cited by this paper
• Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.

  1995cited by this paper
• Changes in health-related quality of life and depression in heart transplant recipients.

  1995cited by this paper
• Effect of pravastatin on outcomes after cardiac transplantation.

  1995cited by this paper
• Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.

  1995cited by this paper
• Allograft diastolic dysfunction and chronotropic incompetence limit cardiac output response to exercise two to six years after heart transplantation.

  1995cited by this paper
• Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection.

  1995cited by this paper
• Evidence against reinnervation of cardiac vagal afferents after human orthotopic cardiac transplantation.

  1995cited by this paper
• Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.

  1995cited by this paper
• Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?

  1995cited by this paper
• Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.

  1995cited by this paper
• Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans.

  1995cited by this paper
• Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.

  1995cited by this paper
• Immune status of recipients following bone marrow-augmented solid organ transplantation.

  1995cited by this paper
• Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.

  1995cited by this paper
• Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.

  1995cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995.

  1995cited by this paper
• Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound.

  1995cited by this paper
• Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.

  1995cited by this paper
• Report of the consensus conference on candidate selection for Heart Transplantation-1993.

  1995cited by this paper
• Extended comparison of quality of life between stable heart failure patients and heart transplant recipients.

  1994cited by this paper
• Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP, and Ca2+.

  1994cited by this paper
• Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.

  1994cited by this paper
• Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.

  1994cited by this paper
• Treatment of acute vascular rejection with immunoadsorption.

  1994cited by this paper
• Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival.

  1994cited by this paper
• Infection after heart transplantation: a multiinstitutional study

  1994cited by this paper
• Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations.

  1993cited by this paper
• Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy.

  1993cited by this paper
• Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans.

  1993cited by this paper
• Coronary artery bypass in patients with severely depressed ventricular function.

  1993cited by this paper
• THE USE OF MYCOPHENOLATE MOFETIL (RS‐61443) IN HUMAN HEART TRANSPLANT RECIPIENTS

  1993cited by this paper
• A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

  1993cited by this paper
• Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.

  1993cited by this paper
• Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure

  1993cited by this paper
• Role of humoral immunity in acute cardiac allograft dysfunction.

  1993cited by this paper
• Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.

  1993cited by this paper
• IN VITRO INDUCTION OF ENDOTHELIAL HLA CLASS II ANTIGEN EXPRESSION BY CYTOMEGALOVIRUS‐ACTIVATED CD4+ T CELLS1

  1993cited by this paper
• Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction: implications of cytomegalovirus association with graft atherosclerosis.

  1993cited by this paper
• 24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization.

  1993cited by this paper
• High-risk cardiac operation: a viable alternative to heart transplantation.

  1993cited by this paper
• 24th Bethesda conference: Cardiac transplantation. Task Force 5: Complications.

  1993cited by this paper
• Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: effect of L-arginine.

  1993cited by this paper
• Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

  1993cited by this paper
• Task force 3: Recipient guidelines/prioritization

  1993cited by this paper
• Heart and lung transplantation 2000

  1993cited by this paper
• Task force 5: Complications

  1993cited by this paper
• Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.

  1992cited by this paper
• Predictors of survival after repeat heart transplantation. The Registry of the International Society for Heart and Lung Transplantation, and Contributing Investigators.

  1992cited by this paper
• The influence of RS-61443 on antibody-mediated rejection.

  1992cited by this paper
• 1990 transplant statistics show more hard times ahead.

  1992cited by this paper
• Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography.

  1992cited by this paper
• Predictors of survival after repeat heart transplantation

  1992cited by this paper
• Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.

  1992cited by this paper
• Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies.

  1992cited by this paper
• Long-term results in diabetic patients undergoing heart transplantation.

  1992cited by this paper
• 1990 transplant statistics show more hard times ahead.

  1992cited by this paper
• Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

  1992cited by this paper
• Transplant coronary artery disease: histopathologic correlations with angiographic morphology.

  1991cited by this paper
• The role of anti-HLA antibodies in heart transplantation.

  1991cited by this paper
• Evidence for Structural Sympathetic Reinnervation After Orthotopic Cardiac Transplantation in Humans

  1991cited by this paper
• Psychosocial profile of noncompliant transplant patients.

  1991cited by this paper
• Clinical manifestations of vascular rejection in cardiac transplantation.

  1991cited by this paper
• Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.

  1991cited by this paper
• Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection.

  1991cited by this paper
• Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens.

  1991cited by this paper
• Intracoronary Ultrasound in Cardiac Transplant Recipients: In Vivo Evidence of “Angiographically Silent” Intimal Thickening

  1991cited by this paper
• Chest pain in cardiac-transplant recipients. Evidence of sensory reinnervation after cardiac transplantation.

  1991cited by this paper
• Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.

  1991cited by this paper
• Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure

  1991cited by this paper
• Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells.

  1991cited by this paper
• Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity.

  1990cited by this paper
• Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis.

  1990cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure.

  1990cited by this paper
• Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts.

  1990cited by this paper
• Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.

  1990cited by this paper
• Heart Transplantation in Mildly Diabetic Patients

  1990cited by this paper
• Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis.

  1989cited by this paper
• Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

  1989cited by this paper
• Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.

  1989cited by this paper
• Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.

  1989cited by this paper
• Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.

  1989cited by this paper
• Mechanism of the attenuated peak heart rate response to exercise after orthotopic cardiac transplantation.

  1989cited by this paper
• Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression.

  1989cited by this paper
• Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation.

  1989cited by this paper
• Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection.

  1989cited by this paper
• Extended donor age in cardiac transplantation.

  1989cited by this paper
• Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis.

  1989cited by this paper
• Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.

  1989cited by this paper
• Heart transplantation in elderly patients.

  1988cited by this paper

• Psychosocial and behavioural factors in heart transplant candidates – an overview

  2007cites this paper
• Attention to child development: a key piece of family-centered care for cardiac transplant recipients.

  2006cites this paper
• Pretreatment With Angiotensin Receptor Blockade Prevents Left Ventricular Dysfunction and Blunts Left Ventricular Remodeling Associated With Acute Myocardial Infarction

  2006cites this paper
• Intrathoracic organ transplantation in the United Kingdom 1995–99: results from the UK cardiothoracic transplant audit

  2002cites this paper
• Economic trends and issues related to heart transplantation.

  2000cites this paper
• Cardiac transplantation in patients with refractory ventricular arrhythmias.

  2000cites this paper
• Evaluation criteria for the pretransplant patient.

  2000cites this paper
• [Heart and liver transplantation in adolescents. Results of an expert survey].

  1999cites this paper
• Heterogeneous basal expression of nitric oxide synthase and superoxide dismutase isoforms in mammalian heart : implications for mechanisms governing indirect and direct nitric oxide-related effects.

  1999cites this paper
• Herz- bzw. Lebertransplantation bei Jugendlichen. Ergebnisse einer Expertenbefragung

  1999cites this paper